[Federal Register Volume 66, Number 45 (Wednesday, March 7, 2001)]
[Notices]
[Page 13816]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-5676]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


In the Matter of Ives Health Co. Inc.; Order of Suspension of 
Trading

March 5, 2001.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Ives Health Company, Inc., an Oklahoma corporation, with its principal 
place of business in Claremore, Oklahoma. Questions have been raised 
about the adequacy and accuracy of publicly disseminated information 
concerning, among other things, a product being marketed by Ives Health 
for treatment of human immunodeficiency virus (HIV).
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of Ives Health.
    Therefore, it is ordered, pursuant to section 12(k) of the 
Securities Exchange Act of 1934, that trading in the securities of Ives 
Health Company, Inc. is suspended for the period from 9:30 a.m. EST, 
March 5, 2001, through 11:59 p.m. EST, March 16, 2001.

By the Commission.
Margaret H. McFarland,
Deputy Secretary.
[FR Doc. 01-5676 Filed 3-5-01; 1:12 pm]
BILLING CODE 8010-01-M